Nevertheless, the evolution of plasma GFAP in relation to brain Aβ/tau burden, as well as the exact interaction between astrocyte activation and Aβ deposition in the advanced pathological stages of AD, warrants further investigation. This evidence concerns the gene GFAP and Alzheimer disease.